Do you think this treatment will be permanent and you don't need to repeat it every few years?
dNovo new promissing player in the stemcell race
- Thread starter byebyehair
- Start date
It’s impossible to know or to even speculate about it because the company has shared very little actual technical info about what they are doing.
still many years away, this will be for 2000+ generation not for older
the qustions are, when, how much and if it will be permanent.....
- Reaction score
- 188
That doesn't really mean anything. They'll get their patent
It means that they are pushing the marketing angle too hard. And people usually do that to overcompensate a lack of product substance. That’s the point Paul G was making I believe.
This is similar to what Replicel was trying to do. Only replicel couldn't expand dermal papilla cells, they had to use DSC cells and hope they would repopulate the DP. That didn't work. What this company is doing is much better, but the process should not be significant more involved. Replicel quoted an expected retail price of $1,800.
the price of 10k $ would be affordable for the vast majority of people, in terms of profits these people would make a fortune
Paul Graham thinks it’s a red flag when a startup puts “patent pending” in their description (so stuffing that terms many times like dNovo did is a multiple of red flags)
but some people here apparently doesn’t have the cerebral capacity to understand why so I’ll leave at that
but some people here apparently doesn’t have the cerebral capacity to understand why so I’ll leave at that
I don’t know. Replicel was aiming to stimulate dead hairs back to life, while dNovo is trying to create new ones?
Their marketing speak is rather loose so it’s hard to know for sure, but their name comes from de novo which implies brand new hairs
Does he think it's a red flag, or does he just not want to wait? Obviously if the patent is denied then a company has no business so its not wise to invest unless you have a high degree of certainty that it will be approved, and you are getting good terms
Last edited:
- Reaction score
- 188
A patent is assumed in biotech otherwise it's worthless. Considering that they are at ycombinator I don't think it's a huge deal.
Dude, the irony is painful. Paul Graham is a founder of Y Combinator, the startup accelerator who funded these guys.
Do you know who Paul Graham is? He literally paid them himself yet you're using him as a reason why these guys are a red flag
Last edited:
Dude, put 2 + 2 together - I posted his quote because precisely of who he is, it so naive of your part to think it was just a coincidence that he is behind of YC, lolDude, the irony is painful. Paul Graham is a founder of Y Combinator, the startup accelerator who funded these guys.
Do you know who Paul Graham is? He literally paid them himself yet you're using him as a reason why these guys are a red flag
But Paul Graham is not running YC anymore, dude moved to England and doesn’t participate, at least directly, in their investments process for years. But if he was still involved in reading company applications, he would sure roll his eyes at the “patent pending” stuffing dNovo put in their website. That’s the irony.
Why? The patent is pending, what is wrong with that? What do you want them to say?
They're using the exact same philosophies that he used when he founded it so I'm not sure I understand what your point is. They've raised like 2.5 million now or something, can't believe it with all those red flags.
Last edited:
They could say somewhere that they have a patent pending something, but the way they put it in the text, repeatedly, make it seem like they are using the term as a vanity metric trying to impress the uneducated audience on that subject
Look, if Pauk Graham gets bad a knee jerk reaction after seeing a certain term being used in a company description you can bet that’s not for nothing. There is a pattern there.